「sy」の検索結果
93件：86～90件目を表示
-
tial cation channel subfamily V member 1 (TRPV1) *1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial ...
https://www.senju.co.jp/system/files/content_news/2026-04/ENG_20260406_0.pdf -
Production | About Senju | SENJU Pharmaceutical
Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject
https://www.senju.co.jp/english/about/production.html -
ntial cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial ...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222_0.pdf -
Production | About Senju | SENJU Pharmaceutical
Trusted pharmaceutical products are created using the latest and best equipment in the environment with rich humanity. As ophthalmic solutions are required to meet the same quality standards as inject
http://www.senju.co.jp/english/about/production.html -
ntial cation channel subfamily V member 1 (TRPV1)*1 antagonist, designed to improve both subjective symptoms and objective signs of DED through inhibition of TRPV1. A pivotal Phase III clinical trial ...
https://www.senju.co.jp/system/files/content_news/2025-12/ENG_20251222.pdf